lystn

ONS member MiKaela Olsen, DNP, APRN-CNS, AOCNS®, FAAN, clinical nurse specialist in the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital and Greenspring Oncology in Baltimore, MD, and member of the Mid-Chesapeake Bay Chapter ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss extravasation of antineoplastic agents used in cancer care and what oncology nurses need to know about administering vesicant chemotherapy. Olsen was the lead editor of the ONS Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice.  Music Credit: "Fireflies and Stardust" by Kevin MacLeod  Licensed under Creative Commons by Attribution 3.0  Episode Notes  Check out these resources from today’s episode:  Complete this evaluation for free nursing continuing professional development.  Oncology Nursing Podcast Episode 92: Doxorubicin: The Infamous Red Devil  Oncology Nursing Podcast Episode 121: Home Infusion of Antineoplastics During COVID-19  ONS Voice article: The Case of the Vexing Vesicant  Access Device Standards of Practice for Oncology Nursing  ASCO/ONS Chemotherapy Administration Safety Standards  ONS Book: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice  Clinical Journal of Oncology Nursing article: Chemotherapy Extravasation: Establishing a National Benchmark for Incidence Among Cancer Centers  Clinical Journal of Oncology Nursing article: Venous Flare Reactions: A Case Report of Reactions Following Etoposide Infusion  ONS/ONCC Chemotherapy Immunotherapy Certificate Course